Global Cholesterol Test Market is valued approximately USD 8,537.52 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8% over the forecast period 2022-2029. Cholesterol Test is also known as lipid profile test. This blood test calculates the blood’s triglyceride and cholesterol levels. The Cholesterol Test market is expanding because of factors such as rising. Rising prevalence of cardiovascular disease and growing healthcare infrastructure. Since, Cardiovascular is one of the world’s fastest-growing chronic diseases. Its prevalence has progressively increased during the last few decades.

According to the World Health Organization, Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Furthermore, geriatric, and obese populations are predisposed to chronic diseases in which one third of these deaths occur prematurely in people under 70 years of age. According to the U.S. Department of Health & Human Services, Centers for Disease Control and Prevention almost 2 in 5 adults in the United States have high cholesterol levels which leads to risk for heart disease and stroke, two major causes of death in the United States. In addition, the leading causes of death globally included heart disease, stroke, and chronic obstructive pulmonary disease. There were 8.89 million deaths from heart disease and about 6.19 million deaths caused by stroke. However, incorrect fasting, drugs, and human error may stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cholesterol Test Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the presence of major pharmaceutical and biopharmaceutical companies within the region. According to the Statista, Pharmaceutical sales revenues in the United States have accounted for half of the global total in recent years. Globally 5 out of the ten leading pharmaceutical companies were from the United States generating a record 55 billion U.S. dollars in 2021. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising population and increasing awareness about healthy lifestyle in the market space.

Major market player included in this report are:
Danaher Corporation
F. Hoffmann-La Roche Ltd.,
Merck & Co., Inc.,
Abbott Laboratories,
Randox Laboratories Limited
Thermo fisher scientific,
Abcam plc.,
PerkinElmer, Inc.,
Diazyme Laboratories, Inc.,
Fujifilm Holding Corporation

Recent Developments in the Market:
? In December 2022, Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), announced an exclusive license and collaboration agreement to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. Under the agreement, Kelun-Biotech has granted Merck exclusive global licenses to research, develop, manufacture, and commercialize multiple investigational preclinical ADC therapies and exclusive options to obtain additional licenses to ADC candidates.

Global Cholesterol Test Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Test Type, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Test Kits
Test Strips
Others

By Test Type:
Total Cholesterol Test
High-Density Lipoprotein (HDL) Cholesterol
Low-Density Lipoprotein (LDL) Cholesterol
Triglycerides/VLDL Cholesterol Test

By End User:
Hospitals
Diagnostic Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World